Mingwei Chen
Impact in
-
- Lung Cancer Research Studies
Papers in
-
- Glycosylation and Glycoproteins Research 5
- PI3K/AKT/mTOR signaling in cancer 4
- Cell death mechanisms and regulation 3
- RNA modifications and cancer 3
- Ubiquitin and proteasome pathways 2
- Oncology 12
- Co-authors
- Puyu Shi (7 shared papers)Shi‐Yong Sun (3 shared papers)Suresh S. Ramalingam (3 shared papers)Asmitananda Thakur (6 shared papers)Ping Yue (2 shared papers)Taofeek K. Owonikoko (2 shared papers)Tianjun Chen (4 shared papers)Hui Ren (5 shared papers)
- Journals
- Cancer Letters (2 papers)RSC Advances (2 papers)Tumor Biology (2 papers)Cancer Medicine (2 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesNepal
In The Last Decade
Mingwei Chen
40 papers receiving 683 citations
Peers
Comparison fields: 5 of 79
- Oncology 189
- Cancer Research 100
- Pulmonary and Respiratory Medicine 210
- Molecular Biology 367
- Pathology and Forensic Medicine 57
Countries citing papers authored by Mingwei Chen
This map shows the geographic impact of Mingwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingwei Chen more than expected).
Fields of papers citing papers by Mingwei Chen
This network shows the impact of papers produced by Mingwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingwei Chen. The network helps show where Mingwei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingwei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 149 | |
| 2 | 2012 | 48 | |
| 3 | 2015 | 36 | |
| 4 | 2019 | 35 | |
| 5 | 2021 | 33 | |
| 6 | 2015 | 31 | |
| 7 | 2020 | 30 | |
| 8 | 2019 | 28 | |
| 9 | 2012 | 24 | |
| 10 | 2019 | 22 | |
| 11 | 2023 | 19 | |
| 12 | 2024 | 18 | |
| 13 | 2020 | 17 | |
| 14 | 2014 | 16 | |
| 15 | 2015 | 15 | |
| 16 | 2009 | 14 | |
| 17 | 2017 | 13 | |
| 18 | 2016 | 12 | |
| 19 | 2022 | 12 | |
| 20 | 2016 | 12 |
About Mingwei Chen
Mingwei Chen is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Epidemiology, having authored 42 papers that have together received 685 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (5 papers), Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Cell death mechanisms and regulation (3 papers), RNA modifications and cancer (3 papers), Ubiquitin and proteasome pathways (2 papers), Galectins and Cancer Biology (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Oncology (189 citations), Cancer Research (100 citations), Pulmonary and Respiratory Medicine (210 citations), Molecular Biology (367 citations) and Pathology and Forensic Medicine (57 citations). Mingwei Chen has collaborated with scholars based in China, United States and Nepal. Frequent co-authors include Puyu Shi, Shi‐Yong Sun, Suresh S. Ramalingam, Asmitananda Thakur, Ping Yue, Taofeek K. Owonikoko, Tianjun Chen, Hui Ren, Hui Ren and Yiqian Liang. Their work appears in journals such as Cancer Letters, RSC Advances, Tumor Biology, Cancer Medicine and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.